Ignite Creation Date:
2025-12-24 @ 2:42 PM
Ignite Modification Date:
2026-01-04 @ 8:31 AM
Study NCT ID:
NCT02288559
Status:
COMPLETED
Last Update Posted:
2019-09-25
First Post:
2014-11-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Participants With Geographic Atrophy
Sponsor:
Genentech, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-03-30
Start Date Type:
ACTUAL
Primary Completion Date:
2017-06-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-06-02
Completion Date Type:
ACTUAL
First Submit Date:
2014-11-07
First Submit QC Date:
None
Study First Post Date:
2014-11-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-01-24
Results First Submit QC Date:
None
Results First Post Date:
2019-02-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2018-06-07
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2019-09-23
Last Update Post Date:
2019-09-25
Last Update Post Date Type:
ACTUAL